Effect of Early and Delayed Commencement of Paricalcitol in Combination with Enalapril on the Progression of Experimental Polycystic Kidney Disease
Vitamin D secosteroids are intranuclear regulators of cellular growth and suppress the renin-angiotensin system. The aim of this study was to test the hypothesis that the vitamin D receptor agonist, paricalcitol (PC), either alone or with enalapril (E) (an angiotensin-converting enzyme inhibitor), r...
Enregistré dans:
Auteurs principaux: | Priyanka S. Sagar, Sayanthooran Saravanabavan, Alexandra Munt, Annette T. Y. Wong, Gopala K. Rangan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/90f1a31418fb4508a9399ef95e7e89f3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection
par: Duplancic D, et autres
Publié: (2013) -
Secondary hyperparathyroidism in patient with type 2 diabetes and stages 3–4 chronic kidney disease
par: Lilit V. Egshatyan, et autres
Publié: (2018) -
Feline Polycystic Kidney Disease: An Update
par: Lorie Schirrer, et autres
Publié: (2021) -
Comparison between paricalcitol versus cinacalcet therapy in the management of secondary hyperparathyroidism among prevalent hemodialysis patients
par: Maha A. Behairy, et autres
Publié: (2022) -
Celiac artery dissection in polycystic kidney disease
par: Koichiro Yamamoto, et autres
Publié: (2021)